Environmental enrichment augments the efficacy of idiotype vaccination for B-cell lymphoma

Journal of Immunotherapy

Volumn 30, Issue 5, 2007, Pages 517-522

  Benaroya Milshtein, Noa ^a,b   Apter, Alan ^b   Yaniv, Isaac ^a,b   Kukulansky, Tova ^a   Raz, Nava ^a   Haberman, Yael ^a   Halpert, Hila ^a   Pick, Chaim G ^a   Hollander, Nurit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

B cell lymphoma; Enriched environment; Idiotype vaccine; Immunotherapy; Psychoneuroimmunology

Indexed keywords

IDIOTYPIC ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENVIRONMENTAL ENRICHMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REJECTION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CANCER VACCINES; CELL LINE; HOUSING, ANIMAL; IMMUNOTHERAPY; LYMPHOMA, B-CELL; MALE; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; VACCINATION;

EID: 34250881635     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31804efc5e     Document Type: Article

References (42)

1. Rosenzweig MR, Bennett EL, Hebert M, et al. Social grouping cannot account for cerebral effects of enriched environments. Brain Res. 1978;153:563-576.
2. van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. 2000;1:191-198.
3. Kingston SG, Hoffman-Goetz L. Effect of environmental enrichment and housing density on immune system reactivity to acute exercise stress. Physiol Behav. 1996;60:145-150.
4. Schapiro SJ. Effects of social manipulations and environmental enrichment on behavior. Pharmacol Biochem Behav. 2002;73: 271-278.
5. Marashi V, Barnekow A, Ossendorf E, et al. Effects of different forms of environmental enrichment on behavioral, endocrinological, and immunological parameters in male mice. Horm Behav. 2003; 43:281-292.
6. Benaroya-Milshtein N, Hollander N, Apter A, et al. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur J Neurosci. 2004;20: 1341-1347.
7. Ben-Eliyahu S, Page GG, Yirmiya R, et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80:880-888.
8. Brittenden J, Heys SD, Ross J, et al. Natural killer cells and cancer. Cancer. 1996;77:1226-1243.
9. Herberman RB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science. 1981;214:24-30.
10. Kaminski MS, Kitamura K, Maloney DG, et al. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein. J Immunol. 1987;138:1289-1296.
11. Haimovich J, Kukulansky T, Weissman B, et al. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice. Cancer Immunol Immunother. 1999;47:330-336.
12. Hsu FJ, Caspar CB, Czerwinski D, et al. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long-term results of a clinical trial. Blood. 1997;89:3129-3135.
13. Reichardt VL, Okada CY, Liso A, et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - a feasibility study. Blood. 1999; 93:2411-2419.
14. Bergman Y, Haimovich J. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur J Immunol. 1977;7:413-417.
15. Eshhar Z, Blatt C, Bergman Y, et al. Induction of secretion of IgM from cells of the B cell line 38C13 by somatic cell hybridization. J Immunol. 1979;122:2430-2434.
16. Perek Y, Hurwitz E, Burowski D, et al. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM. J Immunol. 1983;131: 1600-1603.
17. Maloney DG, Kaminski MS, Burowski D, et al. Monoclonal antiidiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma. 1985;4:191-209.
18. George AJ, Tutt AL, Stevenson FK. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. J Immunol. 1987;138:628-634.
19. Campbell MJ, Esserman L, Byars NE, et al. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990; 145:1029-1036.
20. van Ojik HH, Bevaart L, Dahle CE, et al. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations. Cancer Res. 2003;63:5595-5600.
21. Iannello A, Ahmad A. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev. 2005;24:487-499.
22. Kwak LW, Young HA, Pennington RW, et al. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci U S A. 1996;93: 10972-10977.
23. Cohen S, Haimovich J, Hollander N. B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice. J Immunother. 2005;28:461-466.
24. Schapiro SJ, Nehete PN, Perlman JE, et al. Effects of dominance status and environmental enrichment on cell-mediated immunity in rhesus macaques. Appl Anim Behav Sci. 1998;56:319-332.
25. Marashi V, Barnekow A, Sachser N. Effects of environmental enrichment on males of a docile inbred strain of mice. Physiol Behav. 2004;82:765-776.
26. Diamond MC. Response of the brain to enrichment. An Acad Bras Cienc. 2001;73:211-220.
27. Rosenzweig MR, Bennett EL. Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav Brain Res. 1996;78:57-65.
28. Ader R. On the development of psychoneuroimmunology. Eur J Pharmacol. 2000;405:167-176.
29. Bardos P, Degenne D, Lebranchu Y, et al. Neocortical lateralization of NK activity in mice. Scand J Immunol. 1981;13:609-611.
30. Barneoud P, Neveu PJ, Vitiello S, et al. Brain neocortex immunomodulation in rats. Brain Res. 1988;474:394-398.
31. Renoux G. The cortex regulates the immune system and the activities of a T cell specific immunopotentiator. Int J Neurosci. 1988;39:177-187.
32. Diamond MC, Weidner J, Schow P, et al. Mental stimulation increases circulating CD4-positive T lymphocytes: a preliminary study. Cogn Brain Res. 2001;12:329-331.
33. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev. 2000;80: 1055-1081.
34. MacNeil B, Hoffman-Goetz L. Chronic exercise enhances in vivo and in vitro cytotoxic mechanisms of natural immunity in mice. J Appl Physiol. 1993;74:388-395.
35. Jonsdottir IH. Exercise immunology: neuroendocrine regulation of NK-cells. Int J Sports Med. 2000;21:S20-S23.
36. Kapasi ZF, Catlin PA, Beck J, et al. The role of endogenous opioids in moderate exercise training-induced enhancement of the secondary antibody response in mice. Phys Ther. 2001;81: 1801-1809.
37. Kohut ML, Arntson BA, Lee W, et al. Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine. 2004;22:2298-2306.
38. Suzuki K, Tagami K. Voluntary wheel-running exercise enhances antigen-specific antibody-producing splenic B cell response and prolongs IgG half-life in the blood. Eur J Appl Physiol. 2005;94: 514-519.
39. Woods JA. Exercise and resistance to neoplasia. Can J Physiol Pharmacol. 1998;76:581-588.
40. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17:S27-S36.
41. Marsland AL, Cohen S, Rabin BS, et al. Trait positive affect and antibody response to hepatitis B vaccination. Brain Behav Immun. 2006;20:261-269.
42. Westerlind KC. Physical activity and cancer preventionmechanisms. Med Sci Sports Exerc. 2003;35:1834-1840.